Robert P. Lenk, Director at PLUS THERAPEUTICS, INC. (PSTV), sold 1,500 shares at $0.31 ($465) on 2022-12-30, disclosed to the SEC on 2023-01-04.
Open-market sale of $465 PSTV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PSTV | BUY | 2023-11-17 | $4K | — | Filing → |
| PSTV | BUY | 2023-11-15 | $9K | — | Filing → |
| PSTV | BUY | 2023-11-13 | $15K | — | Filing → |